Glympa 10/5
- Linagliptin is prescribed for adults with type 2 diabetes mellitus to improve blood sugar control.
- It inhibits the enzyme DPP-4, enhancing insulin release and reducing glucagon levels to regulate glucose.
- Administered once daily, it can be used alone or in combination with other diabetes medications.
- Commonly well-tolerated, side effects may include hypoglycemia; pancreatitis is rare.
Glympa 25/5
- Linagliptin is prescribed for adults with type 2 diabetes mellitus to improve blood sugar control.
- It inhibits the enzyme DPP-4, enhancing insulin release and reducing glucagon levels to regulate glucose.
- Administered once daily, it can be used alone or in combination with other diabetes medications.
- Commonly well-tolerated, side effects may include hypoglycemia; pancreatitis is rare.